Found: 49
Select item for more details and to access through your institution.
Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI.
- Published in:
- European Radiology, 2024, v. 34, n. 5, p. 3087, doi. 10.1007/s00330-023-10215-z
- By:
- Publication type:
- Article
Immunosensitization with a Bcl-2 small molecule inhibitor.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 699, doi. 10.1007/s00262-008-0592-4
- By:
- Publication type:
- Article
Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 9, p. 1279, doi. 10.1007/s00262-008-0461-1
- By:
- Publication type:
- Article
Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 4, p. 179, doi. 10.1007/s00262-002-0269-3
- By:
- Publication type:
- Article
Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 4, p. 190, doi. 10.1007/s00262-002-0270-x
- By:
- Publication type:
- Article
Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 6, p. 285, doi. 10.1007/s002620100202
- By:
- Publication type:
- Article
Cover Image, Volume 36, Issue 6.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Amine‐weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors.
- Published in:
- NMR in Biomedicine, 2023, v. 36, n. 6, p. 1, doi. 10.1002/nbm.4785
- By:
- Publication type:
- Article
Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37564-w
- By:
- Publication type:
- Article
SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 423, doi. 10.1007/s11060-019-03126-x
- By:
- Publication type:
- Article
Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 134, n. 1, p. 29, doi. 10.1007/s11060-017-2507-8
- By:
- Publication type:
- Article
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 4, p. 647, doi. 10.1007/s00401-023-02617-6
- By:
- Publication type:
- Article
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.
- Published in:
- Nature, 2010, v. 465, n. 7300, p. 966, doi. 10.1038/nature09132
- By:
- Publication type:
- Article
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.
- Published in:
- Nature, 2009, v. 462, n. 7274, p. 739, doi. 10.1038/nature08617
- By:
- Publication type:
- Article
Organ and effective dose estimates for patients undergoing hepatic arterial embolization for treatment of liver malignancy.
- Published in:
- Medical Physics, 2011, v. 38, n. 2, p. 736, doi. 10.1118/1.3533685
- By:
- Publication type:
- Article
Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 19, p. 1458, doi. 10.1093/jnci/djs357
- By:
- Publication type:
- Article
Evidence for Innate and Adaptive Immune Responses in a Cohort of Intractable Pediatric Epilepsy Surgery Patients.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00121
- By:
- Publication type:
- Article
Bioluminescent Imaging of Melanoma in Live Mice.
- Published in:
- Journal of Investigative Dermatology, 2005, v. 125, n. 1, p. 159, doi. 10.1111/j.0022-202X.2005.23759.x
- By:
- Publication type:
- Article
Lentiviral Vectors with CMV or MHCII Promoters Administered In Vivo: Immune Reactivity Versus Persistence of Expression.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 7, p. 1390, doi. 10.1038/sj.mt.6300180
- By:
- Publication type:
- Article
993. Optical Bioluminescence and Immunologic Analyses of Lentiviral Vectors Administered In Vivo: Transcriptional Targeting through an MHCII Promoter Yields Persistent Transgene Expression and Lack of CTL Stimulation in Immunocompetent Mice Indicating Tolerance
- Published in:
- Molecular Therapy, 2006, v. 13, p. S382, doi. 10.1016/j.ymthe.2006.08.1086
- By:
- Publication type:
- Article
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01362-2
- By:
- Publication type:
- Article
EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy.
- Published in:
- Science Signaling, 2009, v. 2, n. 101, p. 1, doi. 10.1126/scisignal.2000446
- By:
- Publication type:
- Article
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses.
- Published in:
- PLoS ONE, 2023, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0280364
- By:
- Publication type:
- Article
Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1.
- Published in:
- Nature Communications, 2021, v. 12, p. 1, doi. 10.1038/s41467-021-24293-4
- By:
- Publication type:
- Article
Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0032614
- By:
- Publication type:
- Article
Cellular and vaccine therapeutic approaches for gliomas.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 100, doi. 10.1186/1479-5876-8-100
- By:
- Publication type:
- Article
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities.
- Published in:
- Cancer & Metabolism, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40170-018-0177-4
- By:
- Publication type:
- Article
Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen.
- Published in:
- International Immunology, 2009, v. 21, n. 2, p. 155, doi. 10.1093/intimm/dxn133
- By:
- Publication type:
- Article
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26940-2
- By:
- Publication type:
- Article
Author Correction: TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Author Correction: TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48073-y
- By:
- Publication type:
- Article
Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1176994
- By:
- Publication type:
- Article
CANCER IMMUNOTHERAPY AT THE CROSSROADS: HOW TUMORS EVADE IMMUNITY AND WHAT CAN BE DONE.
- Published in:
- 2004
- By:
- Publication type:
- Book Review
Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-a and interferon-? treatment of human glioblastoma multiforme.
- Published in:
- Journal of Neurosurgery, 2004, v. 100, n. 2, p. 310, doi. 10.3171/jns.2004.100.2.0310
- By:
- Publication type:
- Article
Systemic Adoptive-Cell-Transfer Immunotherapy for High-Grade Meningiomas Targeting NYESO-1 Using TCR-transduced T-Cells.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 5, p. 78, doi. 10.3171/2022.5.JNS.AANS2022abstracts
- By:
- Publication type:
- Article
The future of cancer immunotherapy for brain tumors: a collaborative workshop.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 107, n. 1, p. 197, doi. 10.1007/s11060-011-0737-8
- By:
- Publication type:
- Article
Commentary on "Dysfunctional dendritic cells limit antigen-specific T cell response in glioma".
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 277, doi. 10.1093/neuonc/noac256
- By:
- Publication type:
- Article
Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 6, p. 1020, doi. 10.1093/neuonc/noab276
- By:
- Publication type:
- Article
Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1425, doi. 10.1093/neuonc/noaa154
- By:
- Publication type:
- Article
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1184, doi. 10.1093/neuonc/noz078
- By:
- Publication type:
- Article
IMMU-22. SINGLE-CELL CHARACTERIZATION OF INTRATUMORAL AND SYSTEMIC IMMUNE POPULATIONS IN PEDIATRIC AND ADULT BRAIN TUMORS REVEALS DIFFERENCES IN SUBPOPULATION COMPOSITION, ACTIVATION AND MEMORY.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii97, doi. 10.1093/neuonc/noz036.141
- By:
- Publication type:
- Article
ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi6, doi. 10.1093/neuonc/noy148.020
- By:
- Publication type:
- Article
IMMU-37. VEMURAFENIB ENHANCES THE CYTOTOXICITY OF NY-ESO-1 TCR ENGINEERED T-CELLS FOR BRAF MUTANT BRAIN TUMORS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi129, doi. 10.1093/neuonc/noy148.540
- By:
- Publication type:
- Article
Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 796, doi. 10.1093/neuonc/now287
- By:
- Publication type:
- Article
Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 3, p. 368, doi. 10.1093/neuonc/nov153
- By:
- Publication type:
- Article
pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1514, doi. 10.1093/neuonc/nov106
- By:
- Publication type:
- Article
Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase–1 mutation.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 12, p. 1465, doi. 10.1093/neuonc/nos258
- By:
- Publication type:
- Article